November 18, 2026
Health news, explained with evidence
LIVE
CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Recall Issued for Generic Propranolol Over Potential Metal Contamination Understanding Food Science: Why Some Leftovers Freeze Better Than Others Could an mRNA Vaccine Help Treat Acne? AI-Generated Hospital Discharge Summaries Outperform Human Versions in Clinical Study FDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Recall Issued for Generic Propranolol Over Potential Metal Contamination Understanding Food Science: Why Some Leftovers Freeze Better Than Others Could an mRNA Vaccine Help Treat Acne? AI-Generated Hospital Discharge Summaries Outperform Human Versions in Clinical Study FDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee

mRNA Vaccine Shows Potential for Treating Multiple Food Allergies

🔬 Research 1 min read 👁 7

Researchers at the Technical University of Denmark have developed a novel mRNA vaccine that may help the immune system recognize and block multiple related food allergens. Early results in mice demonstrate a strong protective antibody response.

mRNA Vaccine Shows Potential for Treating Multiple Food Allergies🔬Research

Photo: Medical Xpress

Key points

  • The vaccine uses mRNA technology to teach the immune system to recognize and block multiple related food allergens.
  • In animal studies, the vaccine triggered a strong antibody response against several common allergens.
  • Researchers are currently refining the vaccine delivery system and planning larger studies to test efficacy against severe reactions like anaphylaxis.

Scientists at the Technical University of Denmark (DTU) have developed a new vaccine candidate designed to address the underlying causes of food allergies. By utilizing mRNA technology—similar to the platform used for COVID-19 vaccines—the researchers created a synthetic allergen that acts as a blueprint for the immune system. The goal is to train the body to produce protective antibodies that intercept and neutralize allergens before they trigger a harmful reaction.

The study, published in Nature Communications, tested the vaccine on both healthy and allergic mice. Findings indicated that the vaccine successfully prompted the production of antibodies capable of targeting a range of related allergens, such as those found in specific nuts and fruits. Laboratory tests further showed that these antibodies could reduce allergic reactions in human blood samples.

What to know: While these results serve as a promising proof of concept, the study is in its early stages. The vaccine did not provide complete protection against anaphylaxis in the tested mice, and further research is required to determine optimal dosing and safety in humans. Always consult with a healthcare professional regarding personal medical conditions and allergy management.

Source Medical Xpress — medicalxpress.com/news/2026-11-vaccine-multiple-food-allergies.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.